Amazon ended the year with better-than-expected fourth-quarter earnings and revenue, helped by a record-breaking holiday season and ongoing efforts to cut costs.
Balfaxar is indicated for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients.
Rite Aid has completed its previously announced sale of the Elixir Solutions business to MedImpact Healthcare Systems for approximately $576.5 million.
DSN spoke with founder and CEO Maya Smith about the brand’s origins, how it differs from other hair care solutions on the market and what the future of the company looks like.
The company shared that it is rolling out special-edition boxes of the cereal featuring names of those who have inspired its consumers to make heart-healthy choices.